Open original FDA record ↗Recall record
- FDA identifier
- Z-1108-2021
- Company in FDA record
- Helena Laboratories, Corp.
- FDA record creation date
- Feb 11, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Intermittent potential for shorter than expected clot times.
Source facts
- Action
- On 01/05/2021, the firm sent an "URGENT MEDICAL DEVICE RECALL" Notification Letter via email to it distributors informing them that this Recall has been identified due to the potential for shorter than expected clot times on abnormal patients and on abnormal controls on some cards from specific lots and the use of these products may include difficulty achieving abnormal control results in range and incorrectly low patient results. Distributors were instructed to: 1) Immediately examine their inventory and quarantine the specific product lots 2) If they have further distributed the affected product, they are to identify these customers and notify them at once. In addition, the notification to their customers may be enhanced by including a copy of the recall notification letter, which must include instruction of what customers should do with the recalled product. 3) Complete and return enclosed response form as soon as possible Any questions, email or contact Dr. Jessica Jones Hanka at jhanka@helena.com or 1-800-231-5663 ext. 1177. Distributors were contacted by email and requested to evaluate inventory while the Recalling Firm investigated issue . Distributors were formally notified of recall on 1/5/2021 and provided with a template for a notification letter to translate and send to end users in each country. End users will be asked to return unused product to the distributor, and distributors will forward all returned product to Helena Labs. Distributors will be asked to provide an account of all product distributed. Effectiveness will be determined by evaluating the total product returned and the total product accounted for based on information provided by distributors.
- Initiated
- 2021-01-05
- Root cause
- Under Investigation by firm
- Terminated
- 2024-11-19
- Distribution
- Worldwide distribution - U.S. Nationwide distribution and the countries of Germany, Italy, Romania, Australia, Chile.
- Recall number
- Z-1108-2021
- Recall status
- Terminated
- CDRH record ID
- 185445
- FDA record created
- 2021-02-11
- Recall event number
- 87151